Severe symptomatic hyponatremia during citalopram therapy

American Journal of the Medical Sciences

Volumn 321, Issue 2, 2001, Pages 159-160

  Odeh, Majed ^a,b   Beny, Ahuva ^a   Oliven, Arie ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b NONE   (Israel)

Author keywords

Citalopram; Hyponatremia; Selective serotonin reuptake inhibitors; Syndrome of inappropriate secretion of antidiuretic hormone

Indexed keywords

CITALOPRAM; SODIUM;

AGED; ARTICLE; CASE REPORT; DEPRESSION; FEMALE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; SODIUM BLOOD LEVEL;

EID: 0035153287     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200102000-00009     Document Type: Article

References (13)

1. Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness
2. Update in the pharmacotherapy of depression
3. Citalopram in doses of 20-60 mg is effective in depression relapse prevention: A placebocontrolled 6 month study
4. Citalopram overdosereview of cases treated in Swedish hospitals
5. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: A review of spontaneous reports
6. Inappropriate secretion of antidiuretic hormone and SSRIs
7. Adverse effects of selective serotonin reuptake inhibitors. Hyponatremia caused by Schwartz-Bartter syndrome
8. Hyponatremia associated with paroxetine
9. Hyponatremia associated with paroxetine
10. Sertraline and hyponatremia
11. Drug-induced syndrome of inappropriate antidiuretic hormone secretion
12. Severe life-threatening hyponatremia during paroxetine therapy
13. Syndrome of inappropriate secretion of antidiuretic hormone induced by paroxetine